28
total announcements
POLYMED.NS · 15 min delayed
Poly Medicure Limited
Poly Medicure Limited has rescheduled its investor/analyst meet due to exigencies, with the new date being August 27, 2026. The meeting details remain the same, and no unpublished price-sensitive information will be shared.
Poly Medicure Limited
Poly Medicure Limited has announced the schedule of Investors/Analyst Call/Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's officials will hold one-on-one meetings with analysts/investors on specific dates and venues. The meetings are subject to changes due to exigencies and no unpublished price sensitive information will be shared during the meeting.
Poly Medicure Limited
Poly Medicure Limited has cancelled its investor call scheduled for 20th August, 2026 due to exigencies.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange about the schedule of Investors/Analysts Call/Meet.
Poly Medicure Limited
Poly Medicure Limited has published a copy of a newspaper advertisement regarding its 31st Annual General Meeting to be held on September 05, 2026 through video conferencing.
Poly Medicure Limited
Poly Medicure Limited has submitted the transcript of its Q1 FY27 earnings conference call, where the company discussed its financial performance, strategic vision, and leadership changes.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange about General Updates, specifically the book closure/record date for the purpose of Final Dividend for the FY 2025-26.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange that Record date for the purpose of Dividend is 29-Aug-2026.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange about General Updates regarding the dispatch of a letter to shareholders whose e-mail addresses are not registered with the Company/Depositories, providing the exact weblink to access the Annual Report of the Company for FY 2025-26 and the Notice of the ensuing Annual General Meeting, to be held on September, 05, 2026 through Video Conferencing/Other Audio-Visual Means.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange about Shareholders meeting, 31st Annual General Meeting scheduled to be held on September 5, 2026, through Video Conferencing or Other Audio Visual Means.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange about the link to the recording of its earnings conference call held on August 10, 2026, for the quarter ended June 30, 2026.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 regarding the utilization of proceeds received from Qualified Institutions Placement (QIP). The company has raised Rs 99,999.98 lakh and has utilized the funds for the original objects of the issue without any deviation.
Poly Medicure Limited
Poly Medicure Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations, detailing the utilization of proceeds from its Qualified Institutional Placement (QIP) issue.
Poly Medicure Limited
Poly Medicure Limited has published unaudited financial results for the quarter ended June 30, 2026, in newspapers Financial Express and Jansatta on August 9, 2026.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Poly Medicure Limited
Poly Medicure Limited has submitted its Investor Presentation for Q1 FY27, which includes unaudited financial results for the first quarter ended June 30, 2026.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange regarding Resignation of Ravi Prakash, Deputy Company Secretary as KMP of the company w.e.f. August 10, 2026. The company also announced unaudited financial results for the quarter ended June 30, 2026, and other corporate actions.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange regarding Grant of 1476 Options under ESOP Scheme, 2020, and approval of financial results for the first quarter ended on 30th June 2026.
Poly Medicure Limited
Poly Medicure Limited has informed the Exchange regarding Allotment of 1975 Shares under ESOP Scheme, 2020, and the Board of Directors at their meeting held on August 7, 2026, approved the allotment of 1,975 Equity Shares to its eligible employees. The company also announced its unaudited financial results for the quarter ended June 30, 2026.
Poly Medicure Limited
Poly Medicure Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹43,109.95 lakhs and total income at ₹45,974.91 lakhs. The company has also approved the grant of 1,476 stock options under the Employee Stock Option Scheme 2020 and the allotment of 1,975 equity shares to eligible employees. Additionally, the company has re-appointed M/s Jai Prakash & Company as the Cost Auditors for the financial year 2026-27 and announced the resignation of Mr. Ravi Prakash as Deputy Company Secretary and Compliance Officer.